Dr. Colice is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Irving St Nw
#2a38
Washington, DC 20010Phone+1 202-877-2848
Education & Training
- Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1982
- New York University School of MedicineClass of 1976
Certifications & Licensure
- DC State Medical License 1999 - 2018
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Population Pharmacokinetic Modeling and Exposure-Efficacy and Body Weight-Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma.Yanan Zheng, Lubna Abuqayyas, Angelica Quartino, Ye Guan, Yuying Gao
Journal of Clinical Pharmacology. 2024-08-01 - 1 citationsEffect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study.Jeremy Cole, Iwona Cąpała-Szczurko, Stephanie Roseti, Claudia Chen, Scott Caveney
Pulmonary Therapy. 2024-03-01 - 3 citationsEffect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study.Andrew Menzies-Gow, Christopher S Ambrose, Gene Colice, Gillian Hunter, Bill Cook
Advances in Therapy. 2023-11-01
Journal Articles
- Tralokinumab Did Not Demonstrate Oral Corticosteroid-Sparing Effects in Severe AsthmaGene Colice, MD, The European Respiratory Journal
Press Mentions
- Should Fibrinolytics Be Routinely Administered Intrapleurally for Complicated Parapneumonic Effusion?January 7th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: